Here is a question to contemplate (or not...hahaha)

With Hepa's 12.7% share position and the rights to sell in China, Taiwan, etc I had assumed Hepa was a Trojan horse parked outside the RVX castle collecting data and intellegence and continuously learning all aspects of apabetalone in terms of science and the business potential.

It is well known that the Chinese have been intellectual leaders in some centuries. It is also well known that the Chinese are very aggressive at "borrowing" intellectual property, copying it and doing business with it. I am not suggesting Hepa is "borrowing". They paid for it legitimately but they have "it" and they have all of the research they have done themselves.

So now another 30 warriors (43% - 13% = 30% points) have been released from the Trojan horse but they seem to be friendly warriers because they eliminated debt and protected IP. This is to their benefit, particularly if, even pre FA, they believe strongly in the potential of apabetalone.

So my question is "why didn't they buy all of RVX?".

1. They don't have the money?
2. Eastern wouldn't allow it?
3. Don would have made it very expensive?
4. The risk is still too high at this stage?
5. They believe that if the FA fails they will take it all for virtually nothing and they will end up with all of the leading edge epigenetic technology to develop? They willl own the scaffolds and production methods as well.
6. etc.

I am having a very difficult time wrapping my head around any sort of CVR deal. I suppose if a BP made a very significant CVR proposal and Hepa could retain their regional license it would be a significant benefit to their cash position and cash flow.

However, that scenario is very different than owning a leading edge, breakthrough drug (and drug development company) that would have global demand in at least 1 area of unmet needs (CVD, DM, low HDL) and patent protection through 2029 (based on recall) and this does not even include all of the other indications that apabetalone seems to have potential in addressing.

My guess is that they want it all. I'm just hoping for fair treatment. I'm sure we have all been involved in situations that when the opportunity becomes evident the wolves move in and greed takes over. Fiar treatment flies out the window.

This is a very interesting time and we live in an information vacuum re RVX and Zenith.

GLTA

Toinv